Search clinical trials for: HIV risk

Total 27546 results

Kanuni Sultan Suleyman Training and Research Hospital

Completed

Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation

Acquired Immunodeficiency Syndrome | HIV Seropositivity | Pregnancy, High Risk
Boston Medical Center
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort (ZINC)

HIV Infection | Alcohol Use

Russian Federation
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX

HIV Infections | HIV | Substance Abuse

Russian Federation
North Carolina State University
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Reducing HIV Risk Among Adolescents: Evaluating Project HEART

Sexually Transmitted Diseases | HIV

United States
University of Southern California
Centers for Disease Control and Prevention; Charles Drew University of Medicine...

Completed

The HJ MILE HIV Prevention Intervention for Post-incarcerated Men

HIV | Risk Reduction Behavior

United States
Wayne State University
University of California, San Diego

Completed

Targeting PM to Improve HIV Adherence in Adolescents at Risk for Substance Abuse

Substance Abuse | Adherence

United States
Public Health Management Corporation
National Institute on Drug Abuse (NIDA); Mazzoni Center

Completed

Addressing Young Men's Substance Use and HIV Risk (Get REAL)

HIV

United States
Emory University

Completed

Comprehensive HIV Prevention Package for MSM in Southern Africa: Pilot Study (Sibanye Health Project)

HIV

United States, South Africa
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Safer Conception Intervention for HIV-1 Serodiscordant Couples (SCIP)

HIV Seropositivity | Pregnancy, High-Risk

United States, Kenya
Malaysia Palm Oil Board
Universiti Putra Malaysia

Unknown

Anti-Inflammatory Effect of Tocotrienol Supplementation in Subjects With Moderately Elevated Inflammation (INTOC)

Inflammation | Cardiovascular Risk Factor

Malaysia
University of Michigan
National Institute on Drug Abuse (NIDA)

Completed

Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER

Drug Use | Sex Behavior

United States
Wake Forest University Health Sciences
National Institute of Mental Health (NIMH)

Completed

Using CBPR to Reduce HIV Risk Among Immigrant Latino MSM (HOLA)

HIV/AIDS
Hunter College of City University of New York
National Institute on Drug Abuse (NIDA)

Completed

Multicomponent Intervention to Reduce Sexual Risk and Substance Use

HIV | Substance Use | Sexually Transmitted Infections

United States
Charles Drew University of Medicine and Science
University of California, Los Angeles; University of Southern California; Los...

Completed

Reducing HIV Risk With High Risk HIV Negative Black MSM-Passport to Wellness (PtW)

HIV | Men

United States
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen (RALAM-II)

HIV Infections | HIV Seropositivity | HIV-1-infection

Spain
National Institute for Medical Research, Tanzania

Unknown

Cash Transfer to Adolescent Girls and Young Women to Reduce Sexual Risk Behavior - an Impact Evaluation (CARE)

HIV/AIDS | HSV-2 Infection

Tanzania
Ryerson University

Completed

A Small-group Intervention to Reduce HIV Sexual Transmission Risk Behavior Among HIV-positive Men Who Have Sex With Men (GPS)

Risk Behavior
Public Health Institute, California
National Institute on Drug Abuse (NIDA)

Completed

Reducing Offenders' HIV Risk: MI Enhanced Case Management With Drug-Free Housing

Alcohol and Drug Abuse

United States
Montefiore Medical Center
Centers for Disease Control and Prevention

Completed

Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV

HIV-1-infection | Pre-exposure Prophylaxis

United States
Hopital Foch
Saint-Louis Hospital, Paris, France; Bicetre Hospital; European Georges Pompidou... and other collaborators

Completed

Screening Strategy for Asymptomatic Sexually Transmitted Infections (STI) in a Cohort of HIV Outpatients Men Who Have Sex With Men (DRIVER) (DRIVER)

HIV

France
ViiV Healthcare

Completed

Study on Effects of BMS-955176 on the Pharmacokinetics of Probe Substrates

HIV Infections

United States
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

BEing Safe in Treatment (BEST)

Risk Behavior | Substance Use | Risk Reduction | Sex, Unsafe
Fundacion Clinic per a la Recerca Biomédica

Unknown

Diagnostic of Human Immunodeficiency Virus (HIV) and Other Sexual Transmission Diseases (STD) in High Risk Populations: Men Who Have Sex With Men (MSM) Users of Chemsex (Care_ChemS)

HIV
University of Connecticut

Completed

Behavioral Intervention to Enhance HIV Test/Treat

HIV/AIDS

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma

High Risk Non-Hodgkin's Lymphoma

United States
Albert Einstein College of Medicine
National Institute on Drug Abuse (NIDA); The City University of New York; Washington...

Completed

Pilot Test of a Community-based Buprenorphine Treatment Intervention

Opioid Dependence | Injection Drug Use

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.

HIV Infections

United States
Public Health Management Corporation
Centers for Disease Control and Prevention

Completed

Evaluation of a New HIV Prevention Intervention for Black Bisexually-active Men (RISE)

Bisexually-active Men | at Risk for HIV

United States
St Stephens Aids Trust

Completed

Cardiovascular Risk in HIV Patients Switching From a Boosted Protease Inhibitor (PI) to Dolutegravir (DTG)

HIV

Germany, Spain, France, United Kingdom, Belgium, Italy
Johns Hopkins Bloomberg School of Public Health
SHARPZ (Serenity Harm Reduction Programme Zambia)

Completed

Randomized Controlled Trial of Ways to Improve OVC HIV Prevention and Well-being

Risk Behavior | Mental Health Impairment

Zambia
Puerto Rico Community Network for Clinical Research...
Gilead Sciences

Unknown

Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part B

HIV/AIDS

Puerto Rico
Puerto Rico Community Network for Clinical Research...
Gilead Sciences

Unknown

Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part A

HIV/AIDS

Puerto Rico
Massachusetts General Hospital
University of Miami; Fenway Community Health

Completed

HIV Prevention and Trauma Treatment for Men Who Have Sex With Men With Childhood Sexual Abuse Histories (THRIVE)

Stress Disorders, Post-Traumatic | Sexual Risk Behavior | Childhood Sexual Abuse

United States
Kyle Kampman

Completed

Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior (MOD6)

Cocaine Dependence
University Hospital, Basel, Switzerland
Swiss Tropical & Public Health Institute; Ifakara Health Institute

Completed

Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa (RenalOne)

HIV Infections | Hypertension | Diabetes Mellitus | Chronic Kidney Diseases | Tuberculosis | Schistosomiasis

Switzerland
Emory University
Centers for Disease Control and Prevention

Completed

PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV

HIV

United States
Medical College of Wisconsin
Mississippi State University; AIDS Task Force of Greater Cleveland

Completed

Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM) (C3)

HIV

United States
RWTH Aachen University
biosyn Arzneimittel GmbH; Cardiodevice Stiftung

Completed

High-dose Selenium Supplementation in Patients With Left Ventricular Assist (SOS-LVAD)

Ventricular Dysfunction, Left

Germany
Education Development Center, Inc.

Completed

Reducing HIV Risks in African American Teens

HIV Infections

United States
Centre for the AIDS Programme of Research in South...
Johns Hopkins University; National Institute of Allergy and Infectious Diseases...

Completed

STI Care Model to Reduce Genital Inflammation and HIV Risk in South African Women

Sexually Transmitted Diseases | HIV Prevention

South Africa
Boston College
University of Pennsylvania; New York University; University of the West Indies...

Completed

Development and Testing of a Jamaican Mother-daughter HIV Risk-reduction Program

HIV Prevention | Parent-Child Relations | Adolescent Behavior
University Of Perugia

Completed

Efficacy of Maraviroc in Modulating Atherosclerosis in HIV Patients.

Inflammation | Atherosclerosis | Cardiovascular Risk Factor | HIV Infection With Other Conditions

Italy
University of Cape Town
Imperial College London; Institute of Tropical Medicine, Belgium; European and... and other collaborators

Completed

Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone (Pred-ART)

HIV | Tuberculosis | Immune Reconstitution Inflammatory Syndrome

South Africa
Emory University

Terminated

Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women (MIP)

HIV

United States
Yale University
National Institute on Drug Abuse (NIDA); St. Petersburg State Pavlov Medical...

Completed

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia

Opiate Dependence

Russian Federation
Groupe Francophone des Myelodysplasies
Novartis

Unknown

A Study of Combined Deferasirox, Vitamin D and Azacytidine in High Risk MDS (GFM-EXVD-AZA)

MDS

France, Belgium
ANRS, Emerging Infectious Diseases
Merck Sharp & Dohme LLC

Completed

Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study (HAND55-70)

HIV-1 Infection

France
Public Health Solutions
Columbia University; Emory University; Hunter College of City University of New... and other collaborators

Completed

Scale-up of an Internet-Delivered Study for HIV+ Men (Positive View)

HIV

United States
Masonic Cancer Center, University of Minnesota

Completed

Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant

Acute Myelogenous Leukemia

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

The Therapeutic Workplace Initiation Study

Substance Abuse, Intravenous | Opioid-Related Disorders | Heroin Dependence | Cocaine-Related Disorders

United States

Search clinical trials for: HIV risk

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations